Cabotib 40mg Tablet is a medication containing Cabozantinib as its active ingredient. Cabozantinib is a tyrosine kinase inhibitor that works by blocking the activity of certain proteins that promote cancer cell growth and survival. It targets multiple receptor tyrosine kinases, including VEGFR, MET, RET, KIT, and FLT3, which are involved in tumor growth, angiogenesis (the formation of new blood vessels that feed tumors), and metastasis (the spread of cancer to other parts of the body).
Cabotib 40mg Tablet is primarily indicated for the treatment of advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (a type of liver cancer) in patients who have previously received systemic therapy. It may also be used for other types of cancer, depending on the specific diagnosis and treatment guidelines.
The typical dosage of Cabotib 40mg Tablet is determined by a healthcare professional based on the patient’s condition and response to treatment. It is usually taken orally, with or without food. It is crucial to follow the prescribed dosage and duration of treatment. Common side effects may include diarrhea, fatigue, nausea, vomiting, decreased appetite, hypertension, rash, and hand-foot syndrome. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Cabotib 40mg Tablet should be stored at room temperature, away from moisture and heat.
